Project Description

CSA Medical

At CSA Medical®, we aim to be the leading global provider of innovative spray cryotherapy medical device solutions that improve patient outcomes, simplify procedures, and reduce the cost of healthcare.

Our truFreeze® spray cryotherapy technology uses extremely cold liquid nitrogen (-196° C) to provide targeted, touchless ablation of unwanted tissue inside the body under direct visualization.

News & Updates

CSA Medical Receives TEDCO ICE Award for Corporate Excellence

CSA Medical, Inc., the leading provider of truFreeze® advanced spray cryotherapy technology that flash freezes unwanted tissues inside the body, received the Maryland Technology Development Corporation (TEDCO) ICE Award for Corporate Excellence. The awards program [...]

CSA Medical Announces First Patient Procedures with truFreeze® Spray Cryotherapy System

CSA Medical, Inc., the leading provider of advanced spray cryotherapy technology that flash freezes and ablates unwanted tissue inside of the body, today announced the successful first patient procedures with the truFreeze® Spray Cryotherapy System. [...]

CSA Medical Opens New Facility in Lexington, MA

Company triples its space to advance customer training and product development CSA Medical, Inc., the leading provider of advanced spray cryotherapy technology that flash freezes and ablates unwanted tissue inside the body, today announced a [...]

CSA Medical Completes $20.5 Million Series B Financing

Funds to Support Post-Market Clinical Studies and New Indications for Spray Cryotherapy Technology CSA Medical, Inc., the leading developer of novel Spray Cryotherapy devices that freeze and destroy unwanted tissue inside the body, today announced [...]

CSA Medical

New Markets Team Member:

Robb Doub

Sector:

Healthcare

STATUS:

Current

Visit: www.csamedical.com icon_newWindow